- Home
- GPRK vs ITOS Comparison
GPRK vs ITOS Comparison
Compare GPRK & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- ITOS
- Stock Information
- Founded
- GPRK 2002
- ITOS 2011
- Country
- GPRK Colombia
- ITOS United States
- Employees
- GPRK 476
- ITOS N/A
- Industry
- GPRK Oil & Gas Production
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRK Energy
- ITOS Health Care
- Exchange
- GPRK Nasdaq
- ITOS Nasdaq
- Market Cap
- GPRK 351.5M
- ITOS 381.2M
- IPO Year
- GPRK N/A
- ITOS 2020
- Fundamental
- Price
- GPRK $7.06
- ITOS $10.16
- Analyst Decision
- GPRK Buy
- ITOS Hold
- Analyst Count
- GPRK 1
- ITOS 6
- Target Price
- GPRK $11.00
- ITOS $10.60
- AVG Volume (30 Days)
- GPRK 651.0K
- ITOS 914.0K
- Earning Date
- GPRK 08-13-2025
- ITOS 08-07-2025
- Dividend Yield
- GPRK 8.33%
- ITOS N/A
- EPS Growth
- GPRK N/A
- ITOS N/A
- EPS
- GPRK 1.51
- ITOS N/A
- Revenue
- GPRK $630,771,000.00
- ITOS $35,000,000.00
- Revenue This Year
- GPRK N/A
- ITOS N/A
- Revenue Next Year
- GPRK $5.80
- ITOS N/A
- P/E Ratio
- GPRK $4.37
- ITOS N/A
- Revenue Growth
- GPRK N/A
- ITOS 177.89
- 52 Week Low
- GPRK $5.66
- ITOS $4.80
- 52 Week High
- GPRK $11.72
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- GPRK 51.70
- ITOS 67.13
- Support Level
- GPRK $6.45
- ITOS $9.95
- Resistance Level
- GPRK $6.88
- ITOS $10.20
- Average True Range (ATR)
- GPRK 0.31
- ITOS 0.16
- MACD
- GPRK -0.07
- ITOS -0.10
- Stochastic Oscillator
- GPRK 43.26
- ITOS 84.75
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.